The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An overview of adverse event (AE) management for patients (pts) receiving abemaciclib.
 
Hope S. Rugo
Honoraria - Blueprint Medicines; Chugai Pharma; Mylan; Puma Biotechnology; Samsung Bioepis
Consulting or Advisory Role - Napo Pharmaceuticals
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Polyphor (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
 
Alexandra Vitko
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Kelli Thoele
Employment - Lilly
Stock and Other Ownership Interests - Lilly